KDR and glioblastoma: To clarify whether antibody-based Tie2 activation and VEGFR2 blockade can normalize tumor vessels in spontaneous GBM models, we examined the morphology of EGFRVIII GBM tumor vessels after treatment with IgG, 4E2, or DC101.